 |
Research
Survanta has consistently demonstrated a commitment to scientific research. Our company has been a pioneer at the forefront of in-vitro, animal, and clinical research involving RDS in the premature infant. Involvement includes:
- Support for research grants and clinical product studies since 1986. Click here for a list of studies.
- Clinical trials to determine product safety and efficacy.
- Long-term follow-up studies in the premature population.
- Free-of-charge treatment of 8100 neonates during the Treatment Investigational New Drug protocol.
For detailed information on Survanta studies, please see our Bibliography.
For answers to questions that we commonly receive, please refer to our FAQs.
* IMS DDD Lung Surfactant Market Purchases July 1991 through June 2007. On file, Abbott Nutrition Marketing Research.
|
|
